Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 30.87M | 30.06M | 20.81M | 11.44M | 6.94M | 6.19M |
Gross Profit | 1.45M | 2.92M | -700.70K | -1.45M | -1.06M | -180.79K |
EBITDA | -609.19K | -495.13K | -1.00M | -2.45M | -3.56M | -1.69M |
Net Income | -789.38K | -932.86K | -1.54M | -2.79M | -3.81M | -1.91M |
Balance Sheet | ||||||
Total Assets | 4.62M | 5.71M | 5.91M | 6.58M | 4.86M | 3.26M |
Cash, Cash Equivalents and Short-Term Investments | 1.00M | 850.43K | 1.94M | 2.39M | 4.21M | 1.98M |
Total Debt | 1.24M | 1.35M | 302.08K | 521.13K | 71.52K | 2.42M |
Total Liabilities | 3.72M | 4.91M | 4.67M | 4.01M | 1.25M | 4.43M |
Stockholders Equity | 906.83K | 798.37K | 1.24M | 2.57M | 3.61M | -1.16M |
Cash Flow | ||||||
Free Cash Flow | -660.43K | -2.32M | -66.17K | -2.82M | -3.53M | -831.44K |
Operating Cash Flow | -658.82K | -2.21M | 28.20K | -2.47M | -3.50M | -814.65K |
Investing Cash Flow | -207.97K | -289.02K | -346.22K | -811.06K | -21.57K | -16.79K |
Financing Cash Flow | 823.34K | 1.41M | -125.63K | 1.49M | 5.75M | 2.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | AU$68.10M | 10.01 | 71.98% | 6.21% | -5.61% | 16.01% | |
67 Neutral | AU$25.20M | 11.51 | 6.96% | 9.14% | -7.92% | -61.32% | |
65 Neutral | €9.21B | 16.20 | 3.99% | 3.38% | 2.85% | -16.23% | |
52 Neutral | AU$75.54M | 18.92 | -2.93% | 3.28% | -3.90% | -142.61% | |
46 Neutral | AU$7.32M | ― | -245.01% | ― | -17.50% | 66.33% | |
45 Neutral | AU$7.65M | ― | -79.98% | ― | 19.94% | 58.99% | |
€11.95M | 74.99 | 13.66% | 2.68% | ― | ― |
Hiremii Ltd. has announced a proposed issue of securities, including Class A, B, and C Performance Rights, as well as ordinary fully paid shares. This move is expected to impact the company’s operations by potentially increasing its capital base, which could enhance its market positioning and provide additional resources for growth initiatives.
Hiremii Limited has achieved a significant milestone by completing its 2024-25 product roadmap ahead of schedule, introducing a disruptive AI-first tech-recruitment solution. The company’s proprietary AI platform has outperformed industry benchmarks in candidate shortlisting accuracy and has been deployed for a global pharmaceutical client. Despite a slight decline in Q3 FY25 revenue due to a global slowdown, the market is showing signs of recovery, and the company maintains a stable gross profit margin.